SuperworthVital Farms VITL
- Market cap
- $392.4M
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.5×
- EV/EBIT
- 49.6×
- Revenue, 12 months
- $765.7M
- +16% on a year ago
- Net margin
- 0.0%
- Free cash flow yield
- −32.1%
Vital Farms trades at 0.5× sales. Its trailing earnings are negative, so it has no PE. Revenue was $765.7M over the last twelve months, up 16% on a year earlier with a 0% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $110.4M+20% | $135.8M+23% | $147.9M+24% | $147.4M+39% | $145M+31% | $166M+22% | $162.2M+10% | $184.8M+25% | $198.9M+37% | $213.6M+29% | $187.2M+15% | $166M−10% | |
| Cost of revenue | $73.8M+18% | $90.6M+18% | $89M+16% | $89.7M+31% | $91.5M+24% | $106.1M+17% | $99.7M+12% | $113M+26% | $124M+36% | $137.1M+29% | $134.1M+35% | $155.1M+37% |
| Gross profit | $36.7M+24% | $45.2M+36% | $58.9M+38% | $57.7M+53% | $53.5M+46% | $59.9M+33% | $62.5M+6% | $71.8M+25% | $75M+40% | $76.4M+28% | $53M−15% | $10.9M−85% |
| SG&A | $25.1M+22% | $28.8M+31% | $27.1M+13% | $33.3M+39% | $36.1M+44% | $37.4M+30% | $31.9M+18% | $39M+17% | $44.4M+23% | $44.1M+18% | $44.4M+39% | $40.4M+4% |
| $5.2M+158% | $9.1M+164% | $24.2M+122% | $17.1M+113% | $9.2M+77% | $13M+43% | $21.8M−10% | $23.8M+39% | $21.4M+132% | $21.4M+65% | −$2.3M | −$40.1M | |
| Interest expense | $238K+1883% | $269K+209% | $255K+84% | $257K+89% | $259K+9% | $239K−11% | $234K−8% | $218K−15% | $213K−18% | $208K−13% | $190K−19% | $421K+93% |
| Pre-tax income | $5.1M+132% | $9.6M+159% | $24.7M+156% | $18.1M+129% | $10.4M+105% | $14.3M+50% | $22.3M−10% | $24.5M+35% | $22M+112% | $22.4M+57% | −$1.9M | −$40.8M |
| $533K−64% | $2.4M+28% | $5.7M+126% | $1.8M+44% | $2.9M+451% | $3.7M+59% | $5.4M−5% | $7.9M+345% | $5.5M+89% | $6.1M+63% | −$337K | −$9.7M | |
| Net income | $4.5M+526% | $7.2M+287% | $19M+166% | $16.3M+145% | $7.4M+65% | $10.6M+47% | $16.9M−11% | $16.6M+2% | $16.4M+121% | $16.3M+54% | −$1.5M | −$31.1M |
| $0.10+400% | $0.17+325% | $0.43+169% | $0.36+140% | $0.16+60% | $0.23+35% | $0.37−14% | $0.36+0% | $0.36+125% | $0.35+52% | −$0.03 | −$0.72 | |
| 43.1M+1% | 43.3M−1% | 43.8M+1% | 45.2M+5% | 45.5M+5% | 45.7M+6% | 45.8M+5% | 45.8M+1% | 46.2M+2% | 46.2M+1% | 44.6M−3% | 42.9M−6% |
Revenue: Q1 FY19 and Q1 FY20: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY19 and Q1 FY20: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY19 and Q1 FY20: 6 months less the 3 months printed beside them.
SG&A: Q1 FY19 and Q1 FY20: 6 months less the 3 months printed beside them.
Operating income: Q1 FY19 and Q1 FY20: 6 months less the 3 months printed beside them.
Interest expense: Q1 FY19 and Q1 FY20: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY19 and Q1 FY20: 6 months less the 3 months printed beside them.
Income tax: Q1 FY19 and Q1 FY20: 6 months less the 3 months printed beside them.
Net income: Q1 FY19 and Q1 FY20: 6 months less the 3 months printed beside them.
EPS, diluted: 7 periods, Q1 FY19 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q4 FY21: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY22: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution. 3 periods, Q4 FY23 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Packaged Foods nearest Vital Farms' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| VITLVital Farms | $392.4M | n/m | 35.1× | 0.5× | +16% | 0.0% | |
| LWAYLifeway Foods | $339.3M | 32.1× | 31.2× | 1.4× | +26% | 4.5% | |
| MAMAMama's Creations | $604.4M | 75.4× | 57.6× | 2.9× | +54% | 3.5% | |
| SENEASeneca Foods | $1.1B | 9.2× | 8.8× | 0.6× | +12% | 6.7% | |
| BRBRBellring Brands | $1.1B | 6.7× | 34.9× | 0.5× | +6% | 7.3% | |
| FLOFlowers Foods | $1.3B | 23.7× | 26.0× | 0.2× | +2% | 1.1% | |
| JJSFJ&J Snack Foods | $1.6B | 32.2× | 34.9× | 1.0× | −5% | 3.2% | |
| MZTIMarzetti | $3B | 15.6× | 31.1× | 1.5× | +1% | 9.9% | |
| FRPTFreshpet | $3.1B | 17.1× | 80.3× | 2.6× | +13% | 17.3% | |
| POSTPost | $3.5B | 14.9× | 18.8× | 0.4× | +6% | 3.5% | |
| Peer median | $1.3B | 17.1× | 31.2× | 1.0× | +6% | 4.5% |
More on Vital Farms
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
Its groups
About
- Industry
- Packaged Foods
- Sector
- Consumer Defensive
Valuation data, not investment advice. Prices as of .